Abhisek Dwivedy Selected Research

imidazoleglycerolphosphate dehydratase (imidazoleglycerol phosphate dehydratase)

1/2022

Characterization of a triazole scaffold compound as an inhibitor of Mycobacterium tuberculosis imidazoleglycerol-phosphate dehydratase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abhisek Dwivedy Research Topics

Disease

2	Tuberculosis (Tuberculoses) 01/2022 - 01/2017
2	COVID-19 01/2021 - 07/2020
1	Starvation 01/2021
1	Infections 01/2021
1	Severe Acute Respiratory Syndrome 07/2020
1	Hepatitis C 07/2020

Drug/Important Bio-Agent (IBA)

2	Histidine (L-Histidine)FDA Link 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2017
1	imidazoleglycerolphosphate dehydratase (imidazoleglycerol phosphate dehydratase)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 07/2020
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 07/2020
1	Lipase (Acid Lipase)FDA Link 01/2017
1	LipidsIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017

Therapy/Procedure

1	Therapeutics 07/2020